Back to search

Article

Discovery of the first selective M <sub>4</sub> muscarinic acetylcholine receptor antagonists with <i>in vivo</i> anti-parkinsonian and anti-dystonic efficacy

2020-10-12

Abstract excerpt

Non-selective antagonists of muscarinic acetylcholine receptors (mAChRs) that broadly inhibit all five mAChR subtypes provide an efficacious treatment for some movement disorders, including Parkinson disease and dystonia. Despite their efficacy in these and other central nervous system disorders, anti-muscarinic therapy has limited utility due to severe adverse effects that often limit their tolerability by patien...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
06b7b611-e823-5b90-8b1f-b961b2443ceb
DOI
10.1101/2020.10.12.324152
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovery of the first selective M <sub>4</sub> muscarinic acetylcholine receptor antagonists with <i>in vivo</i> anti-parkinsonian and anti-dystonic efficacyDOI 10.1101/2020.10.12.324152
Select a neighboring publication to make it the new centre.